2024 ´ëÇѽɺÎÀüÇÐȸ µ¿°è½ÉÆ÷Áö¾ö : 2024-01-27
±³À°ÀÏÀÚ : 2024-01-27
±³À°Àå¼Ò : ½Ã±×´Ï¿¤ ºÎ»ê, 4Ãþ ±×·£µåº¼·ë
±³À°ÁÖÁ¦ : 2024 ´ëÇѽɺÎÀüÇÐȸ µ¿°è½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѽɺÎÀüÇÐȸ
´ã´çÀÚ : ¹èÀ翬
¿¬¶ôó : 02-3275-5335
À̸ÞÀÏ : kshf3@kshf.or.kr
±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 6 ½Ã°£ 10ºÐ
¼¼ºÎ¼ö°·á : 50,000¿ø
ºñ°í - »çÀüµî·Ï : Àü¹®ÀÇ(30,000¿ø) / ÀüÀÓÀÇ, ÀÓ»ó°»ç(10,000¿ø) / Àü°øÀÇ, °£È£»ç, Á¦¾à»ç ±× ¿Ü ÀÇ·áÁ¾»çÀÚ ¹«·á - ÇöÀåµî·Ï: Àü¹®ÀÇ(50,000¿ø) / ÀüÀÓÀÇ, ÀÓ»ó°»ç(20,000¿ø) / Àü°øÀÇ, °£È£»ç, Á¦¾à»ç ±× ¿Ü ÀÇ·áÁ¾»çÀÚ(10,000¿ø)
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 01¿ù 27ÀÏ ±×·£µåº¼·ë 10:10~10:30 QUEST Trial - Is Qiliqiangxin Really Benefit for Patients? À̼±±â(°í·ÁÀÇ´ë)
±³À°½Ã°£ 01¿ù 27ÀÏ ±×·£µåº¼·ë 10:30~10:50 New Hope for HF? New Era of Anti-obesity Drug ÀÌ»ó¾ð(¿ï»êÀÇ´ë)
±³À°½Ã°£ 01¿ù 27ÀÏ ±×·£µåº¼·ë 10:50~11:10 Aldose Reductase Inhibition in Heart Failure ÀÌÂùÁÖ(¿¬¼¼ÀÇ´ë)
Åä·Ð 01¿ù 27ÀÏ ±×·£µåº¼·ë 11:10~11:30 Discussion ±è¹ÌÁ¤ / ¹ÚÁøÁÖ / ¹ÚÈÆÁØ / À§Áø / Àå¼¼¿ë / Á¶ÇöÀç(°¡Å縯ÀÇ´ë / ¼¿ïÀÇ´ë / °¡Å縯ÀÇ´ë / °¡ÃµÀÇ´ë / °æºÏÀÇ´ë / ¼¿ïÀÇ´ë)
±³À°½Ã°£ 01¿ù 27ÀÏ ±×·£µåº¼·ë 11:30~12:00 Translational Research in Heart Failure Naoki Mochizuki(NCVC, Japan)
Åä·Ð 01¿ù 27ÀÏ ±×·£µåº¼·ë 12:00~12:10 Discussion ¹ÚÈÆÁØ / ¿ÀÀç¿ø / ÇÑÁø(°¡Å縯ÀÇ´ë / ¿¬¼¼ÀÇ´ë / ÀÎÁ¦ÀÇ´ë)
½Ä»ç 01¿ù 27ÀÏ ±×·£µåº¼·ë 12:10~13:10 Lunch ()
±³À°½Ã°£ 01¿ù 27ÀÏ ±×·£µåº¼·ë 13:10~13:30 Why PH & RV is Important in HF? Á¤¿íÁø(°¡ÃµÀÇ´ë)
±³À°½Ã°£ 01¿ù 27ÀÏ ±×·£µåº¼·ë 13:30~13:50 How to Evaluate PH & RV? ÀÌÁÖÈñ(ÃæºÏÀÇ´ë)
±³À°½Ã°£ 01¿ù 27ÀÏ ±×·£µåº¼·ë 13:50~14:10 Treatment Options for PH & RV À±Á¾Âù(°¡Å縯ÀÇ´ë)
Åä·Ð 01¿ù 27ÀÏ ±×·£µåº¼·ë 14:10~14:30 Discussion ¹Ú»ó¹Î / ¹è´ëȯ / ½Å¼ºÈñ / À念¿ì / ÃÖÀÇ¿µ(À»ÁöÀÇ´ë / ÃæºÏÀÇ´ë / ÀÎÇÏÀÇ´ë / °¡ÃµÀÇ´ë / ¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 01¿ù 27ÀÏ ±×·£µåº¼·ë 14:30~15:00 Cardiomyopathy : Basic-Clinical-Translational Research °¼®¹Î(¿¬¼¼ÀÇ´ë)
ÈÞ½Ä 01¿ù 27ÀÏ ±×·£µåº¼·ë 15:00~15:20 Break ()
±³À°½Ã°£ 01¿ù 27ÀÏ ±×·£µåº¼·ë 15:20~15:40 Treatment of HCM Á¤¹ÌÇâ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 01¿ù 27ÀÏ ±×·£µåº¼·ë 15:40~16:00 Fabry Disease: What Needs to Know? ±èÁöÈñ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 01¿ù 27ÀÏ ±×·£µåº¼·ë 16:00~16:20 Cardiac Amyloidosis Treatment: Now and Next Weapons ¼ÕÁ¤¿ì(¿¬¼¼¿øÁÖÀÇ´ë)
Åä·Ð 01¿ù 27ÀÏ ±×·£µåº¼·ë 16:20~16:40 Discussion ±è´Ù·¡ / ±è¹Ì³ª / ¼¼®¹Î / Á¶»óÈ£ / ÃÖÁ¤Çö / Ȳ°æ±¹(¼º±Õ°üÀÇ´ë / °í·ÁÀÇ´ë / °¡Å縯ÀÇ´ë / ÇѸ²ÀÇ´ë / ºÎ»êÀÇ´ë / ÃæºÏÀÇ´ë)
±³À°½Ã°£ 01¿ù 27ÀÏ ±×·£µåº¼·ë 16:40~17:00 How to Diagnose and Treat in My View À±¹ÎÀç(¼¿ïÀÇ´ë)
Åä·Ð 01¿ù 27ÀÏ ±×·£µåº¼·ë 17:00~17:10 Discussion ±è¹Î¼® / ±èÀÀÁÖ / ¹Ú¼º¹Ì / ¼Áö¿ø / ½ÉÁö¿µ / Á¶µ¿Çõ / ÃÖ°¿î / ÃÖ¼ºÈÆ(¿ï»êÀÇ´ë / °í·ÁÀÇ´ë / °í·ÁÀÇ´ë / ¿¬¼¼ÀÇ´ë / ¿¬¼¼ÀÇ´ë / °í·ÁÀÇ´ë / ¿µ³²ÀÇ´ë / ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 01¿ù 27ÀÏ ±×·£µåº¼·ë 17:10~17:30 How to Diagnose and Treat in My View ÇÏ°æÀº(°¡ÃµÀÇ´ë)
Åä·Ð 01¿ù 27ÀÏ ±×·£µåº¼·ë 17:30~17:40 Discussion ±è°èÈÆ / ±èÇüÀ± / ¹ÚÀçÇü / ¾çÅÂÀÏ / À̼ö¿ë / Àü°æÇö / ÇöÁØÈ£ / Ȳ¼®Àç(Àü³²ÀÇ´ë / Àü³²ÀÇ´ë / Ãæ³²ÀÇ´ë / °¡ÃµÀÇ´ë / ºÎ»êÀÇ´ë / ±¹¹Î°Ç°º¸Çè Àϻ꺴¿ø / ¿ï»êÀÇ´ë / °æ»óÀÇ´ë)